Emflaza

Deflazacort

Emflazaは、満5歳以上の患者のデュシェンヌ型筋ジストロフィー(DMD)の治療のために指示されたコルチコステロイドである。
more
パッケージ あたり 錠剤 価格 節約 ご注文
180 tablet
¥ 114.21
¥ 20557.05¥ 114.21
¥ 36344.61
120 tablet
¥ 131.76
¥ 15811.29¥ 131.76
¥ 22123.15
90 tablet
¥ 158.10
¥ 14229.37¥ 158.10
¥ 14221.46
60 tablet
¥ 197.61
¥ 11856.49¥ 197.61
¥ 7110.73
30 tablet
¥ 316.12
¥ 9483.61¥ 316.12
パッケージ あたり 錠剤 価格 節約 ご注文
120 tablet
無料航空便配送 Hot
¥ 724.98
¥ 86997.69¥ 724.98
¥ 15787.56
90 tablet
無料航空便配送 Hot
¥ 764.51
¥ 68805.61¥ 764.51
¥ 8283.33
60 tablet
無料航空便配送 Hot
¥ 790.83
¥ 47449.69¥ 790.83
¥ 3942.94
36 tablet
無料航空便配送 Hot
¥ 834.68
¥ 30048.57¥ 834.68
¥ 787.01
24 tablet
¥ 856.54
¥ 20557.05¥ 856.54
パッケージ あたり 錠剤 価格 節約 ご注文
90 tablet
無料航空便配送 Hot
¥ 878.76
¥ 79088.09¥ 878.76
¥ 15797.45
60 tablet
無料航空便配送 Hot
¥ 949.02
¥ 56941.21¥ 949.02
¥ 6315.82
36 tablet
無料航空便配送 Hot
¥ 1010.45
¥ 36376.25¥ 1010.45
¥ 1577.97
24 tablet
無料航空便配送 Hot
¥ 1054.28
¥ 25302.81¥ 1054.28
Emflaza

ブランド

製造元

  • Lupin

病衣

  • Duchenne Muscular Dystrophy / DMD

Deflazacort tablets

What is this medicine?

Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

What should I tell my health care providers before I take this medicine?

They need to know if you have any of these conditions:

  • Hypersensitivity to deflazacort;
  • Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
  • Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
  • Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
  • Gastrointestinal Perforation: GI disorders;
  • Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
  • Effects on Bones: decreases in bone mineral density;
  • Serious Skin Rashes;
  • Ophthalmic Effects: May include cataracts, infections, and glaucoma;
  • Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.

How should I use this medicine?

The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..

What may interact with this medicine?

  • Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
  • Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.

What side effects may I notice from this medicine?

The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.